Pfizer has reported encouraging mid-stage clinical results for an experimental once-monthly injectable obesity treatment, strengthening its push into one of the most competitive and fast-growing areas of global pharmaceuticals.
Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results
February 4, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
And this is why it's very hard not to be cynical in this system because this committee gets to set its own rules
November 11, 2026 - - Latest News -
The negotiating room is getting smaller as officials narrow the scope
November 11, 2026 - - Latest News -
PBAC sets out its expectations for AI in medicines submissions
November 11, 2026 - -
And this is why it's very hard not to be cynical in this system becasue this committee gets to set its own rules
November 11, 2026 - - Latest News -
Dispatch AI Index finds routine AI use but questions over governance
November 10, 2026 - - News of the Day -
Mayne Pharma sells Salisbury business to Evaris Pharma for $55.5 million
November 10, 2026 - - Latest News -
Bristol Myers Squibb Australia riders more than double their target for Rare Cancers Australia
November 10, 2026 - - Latest News

